InnoModels Biotechnology has always been committed to driving technological innovation in the life sciences, providing scientists with advanced experimental tools. In particular, the company's 3D organoid platform offers a whole new dimension to cellular research and drug discovery.
Definition of 3D Organoid Platform
3D organoid platform is a technology that simulates the microenvironment of human organs by culturing cells in vitro and allowing them to self-organise to form three-dimensional structures. Compared with traditional cell culture technology, 3D organoid platform is more capable of restoring the real biological environment, providing scientists with more reliable research models.
3D organoid platform of InnoModels Biotechnology
InnoModels Biotechnology has made remarkable achievements in the field of 3D organoid platforms, and its technology has outstanding features in the following aspects:
1. Multi-cell type support:
InnoModels Bio's platform supports the self-assembly of multiple cell types and is able to simulate complex organ structures, such as liver, heart, lungs, etc., providing a wide range of application possibilities for research in different fields.
2. Physiological function restoration:
Through well-designed culture conditions and support structures, the platform is able to better restore the physiological functions of organoids, making them closer to the biological properties of organs in vivo.
3. High-throughput screening:
The 3D organoid platform from InnoModels Biotechnology not only provides a highly restored biological environment, but also supports high-throughput experiments to accelerate the drug screening and evaluation process.
4. Customised experimental solutions:
The company provides customised experimental solutions for clients, adapting the technology to the specific needs of the research project to ensure that scientists are able to obtain the data that best meets their research objectives.

Application Areas
InnoModels Bio's 3D organoid platform has demonstrated a wide range of applications in the following areas:
Drug discovery and development:
Providing more realistic and reliable in vitro models for pre-screening and evaluation of drugs, accelerating the drug development process.
Toxicology Research:
Evaluate the toxicity of potential drugs or compounds by restoring the physiological structure and function of organs, providing a reliable basis for drug safety assessment.
Disease modelling:
Using the 3D organoid platform to simulate the microenvironment of a specific disease to establish a more realistic disease model, which helps to study the disease mechanism in depth.
Conclusion
The 3D organoid platform from InnoModels Biotechnology is a catalyst for advancing biomedical research. By providing advanced experimental tools, the company offers scientists a research platform that is closer to the real physiological environment, which will further drive new breakthroughs in drug discovery and disease research.